Amgen Announces New Data Show Greater Bone Mineral Density Gains With Prolia vs Zoledronic Acid

By: via Benzinga
Amgen (NASDAQ: AMGN) today announced findings from a randomized, double-blind, double-dummy, multicenter Phase 4 study showing that ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.